Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
rimegepant 75 mg ODT
DRUG
2 trials
Sponsors
Pfizer
Conditions
Acute Treatment of Migraine
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Phase 3
Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis
Completed
NCT05248997
Pfizer
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Start: 2022-02-17
End: 2024-04-02
Updated: 2025-03-26
Phase 4
A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India
Recruiting
NCT07685769
Pfizer
Acute Treatment of Migraine
Start: 2026-07-24
End: 2028-01-04
Target: 60
Updated: 2026-08-21
Related Papers
Efficacy and safety of rimegepant 75 mg orally disintegrating tablet for the acute treatment of chronic rhinosinusitis in adults: Results from a multicenter, randomized, placebo-controlled, phase 2/3 trial.
2026-03-04